{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:10:22Z","timestamp":1784283022016,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10157-026-02891-0","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:51:10Z","timestamp":1779112270000},"page":"1141-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell based therapy in chronic kidney disease: emerging evidence for a fifth pillar in guideline directed medical therapy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-4470","authenticated-orcid":false,"given":"Gerry George","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2891_CR1","doi-asserted-by":"crossref","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7\u201311.","DOI":"10.1016\/j.kisu.2021.11.003"},{"issue":"4","key":"2891_CR2","doi-asserted-by":"publisher","first-page":"108985","DOI":"10.1016\/j.jdiacomp.2025.108985","volume":"39","author":"J Rollins","year":"2025","unstructured":"Rollins J, Hong AL, Schroader B, Kong SX, Lennert B, Cameron J, Singh R, Du Y, Williamson T. Guideline-directed medical therapies (GDMTs) for chronic kidney disease with type 2 diabetes (CKD\u2009+\u2009T2D): Translation of lessons learned from the management of heart failure. J Diabetes Complic. 2025;39(4):108985.","journal-title":"J Diabetes Complic"},{"issue":"2","key":"2891_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1053\/j.ackd.2016.11.011","volume":"24","author":"HW Schnaper","year":"2017","unstructured":"Schnaper HW. The Tubulointerstitial Pathophysiology of Progressive Kidney Disease. Adv Chronic Kidney Dis. 2017;24(2):107\u201316.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"2891_CR4","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s11255-023-03574-5","volume":"55","author":"S Copur","year":"2023","unstructured":"Copur S, Yavuz F, Covic A, Kanbay M. A review on renal autologous cell transplantation: an investigational approach towards chronic kidney disease. Int Urol Nephrol. 2023;55(10):2539\u201344.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2891_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000537942","volume":"55","author":"J Stavas","year":"2024","unstructured":"Stavas J, Silva AL, Wooldridge TD, Aqeel A, Saad T, Prakash R, Bakris G. Rilparencel (renal autologous cell therapy-REACT\u00ae) for chronic kidney disease and Type 1 and Type 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Redosing Triggers. Am J Nephrol. 2024;55(3):389\u201398.","journal-title":"Am J Nephrol"},{"issue":"1","key":"2891_CR6","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.00164.2016","volume":"311","author":"RL Chevalier","year":"2016","unstructured":"Chevalier RL. The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Ren Physiol. 2016;311(1):F145\u201361.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2891_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40472-016-0107-8","volume":"3","author":"B Wilm","year":"2016","unstructured":"Wilm B, Tamburrini R, Orlando G, Murray P. Autologous cells for kidney bioengineering. Curr Transpl Rep. 2016;3:207\u201320.","journal-title":"Curr Transpl Rep"},{"issue":"6","key":"2891_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1046\/j.1523-1755.2001.00717.x","volume":"59","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59(6):2023\u201338.","journal-title":"Kidney Int"},{"issue":"8","key":"2891_CR9","first-page":"568","volume":"1","author":"L Niksic","year":"2005","unstructured":"Niksic L, Martin PY. La Bone Morphogenic Protein 7 (BMP-7): un espoir dans te traitement de l\u2019insuffisance renale chronique [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?]. Rev Med Suisse. 2005;1(8):568\u201370.","journal-title":"Rev Med Suisse"},{"key":"2891_CR10","doi-asserted-by":"crossref","unstructured":"D\u00edaz Tocados JM, P\u00e9rez G\u00f3mez A, Diego Dom\u00ednguez Coral J, Manuel Valdivielso J. The multiple functions of insulin-like growth factor 1 in kidney disease. Nefrologia (Engl Ed). 2025;45(7):501337.","DOI":"10.1016\/j.nefro.2025.501337"},{"key":"2891_CR11","doi-asserted-by":"publisher","first-page":"4798639","DOI":"10.1155\/2016\/4798639","volume":"2016","author":"AJ Peired","year":"2016","unstructured":"Peired AJ, Sisti A, Romagnani P. Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int. 2016;2016:4798639.","journal-title":"Stem Cells Int"},{"issue":"10","key":"2891_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1681\/ASN.0000000000000189","volume":"34","author":"N Perico","year":"2023","unstructured":"Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, NEPHSTROM Trial Consortium, et al. Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM). J Am Soc Nephrol. 2023;34(10):1733\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"2891_CR13","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.reth.2025.101058","volume":"31","author":"Y Shimizu","year":"2025","unstructured":"Shimizu Y, Inoue Y, Matsuura N, Ishii T, Sowa Y, Sunami H, Ntege EH. Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation. Regen Ther. 2025;31:101058.","journal-title":"Regen Ther"},{"issue":"2","key":"2891_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ajpath.2010.11.044","volume":"178","author":"P Romagnani","year":"2011","unstructured":"Romagnani P. Family portrait: renal progenitor of Bowman\u2019s capsule and its tubular brothers. Am J Pathol. 2011;178(2):490\u20133.","journal-title":"Am J Pathol"},{"issue":"2","key":"2891_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000360669","volume":"126","author":"A Peired","year":"2014","unstructured":"Peired A, Lazzeri E, Lasagni L, Romagnani P. Glomerular regeneration: when can the kidney regenerate from injury and what turns failure into success? Nephron Exp Nephrol. 2014;126(2):70.","journal-title":"Nephron Exp Nephrol"},{"issue":"1","key":"2891_CR16","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1038\/s41598-018-33256-7","volume":"8","author":"S Tajiri","year":"2018","unstructured":"Tajiri S, Yamanaka S, Fujimoto T, Matsumoto K, Taguchi A, Nishinakamura R, Okano HJ, Yokoo T. Regenerative potential of induced pluripotent stem cells derived from patients undergoing haemodialysis in kidney regeneration. Sci Rep. 2018;8(1):14919.","journal-title":"Sci Rep"},{"issue":"3","key":"2891_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/cells9030573","volume":"9","author":"G Bento","year":"2020","unstructured":"Bento G, Shafigullina AK, Rizvanov AA, Sard\u00e3o VA, Macedo MP, Oliveira PJ. Urine-derived stem cells: applications in regenerative and predictive medicine. Cells. 2020;9(3):573.","journal-title":"Cells"},{"issue":"6","key":"2891_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s10157-021-02030-x","volume":"25","author":"K Osafune","year":"2021","unstructured":"Osafune K. iPSC technology-based regenerative medicine for kidney diseases. Clin Exp Nephrol. 2021;25(6):574\u201384.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"2891_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4252\/wjsc.v16.i2.114","volume":"16","author":"HY Long","year":"2024","unstructured":"Long HY, Qian ZP, Lan Q, Xu YJ, Da JJ, Yu FX, Zha Y. Human pluripotent stem cell-derived kidney organoids: Current progress and challenges. World J Stem Cells. 2024;16(2):114\u201325.","journal-title":"World J Stem Cells"},{"key":"2891_CR20","doi-asserted-by":"publisher","first-page":"828369","DOI":"10.4061\/2011\/828369","volume":"2011","author":"D Patschan","year":"2011","unstructured":"Patschan D, Patschan S, M\u00fcller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells\u2019 renoprotective competence. Int J Nephrol. 2011;2011:828369.","journal-title":"Int J Nephrol"},{"issue":"6","key":"2891_CR21","doi-asserted-by":"publisher","first-page":"F1314","DOI":"10.1152\/ajprenal.90755.2008","volume":"296","author":"G Krenning","year":"2009","unstructured":"Krenning G, Dankers PY, Drouven JW, Waanders F, Franssen CF, van Luyn MJ, Harmsen MC, Popa ER. Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Ren Physiol. 2009;296(6):F1314\u201322.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"10","key":"2891_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3109\/0886022X.2012.723592","volume":"34","author":"L Shuai","year":"2012","unstructured":"Shuai L, Li X, He Q, Dang X, Chen H, Zhou P, Yi Z, He X. Angiogenic effect of endothelial progenitor cells transfected with telomerase reverse transcriptase on peritubular microvessel in five out of six subtotal nephrectomy rats. Ren Fail. 2012;34(10):1270\u201380.","journal-title":"Ren Fail"},{"issue":"3","key":"2891_CR23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/jvim.15486","volume":"33","author":"AL Thomson","year":"2019","unstructured":"Thomson AL, Berent AC, Weisse C, Langston CE. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial. J Vet Intern Med. 2019;33(3):1353\u201361.","journal-title":"J Vet Intern Med"},{"key":"2891_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12967-014-0331-x","volume":"12","author":"ME Reinders","year":"2014","unstructured":"Reinders ME, Bank JR, Dreyer GJ, Roelofs H, Heidt S, Roelen DL, Al Huurman V, Lindeman J, van Kooten C, Claas FH, Fibbe WE, Rabelink TJ, de Fijter JW. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J Transl Med. 2014;12:331.","journal-title":"J Transl Med"},{"key":"2891_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ebiom.2016.09.011","volume":"12","author":"DK Packham","year":"2016","unstructured":"Packham DK, Fraser IR, Kerr PG, Segal KR. Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study. EBioMedicine. 2016;12:263\u20139.","journal-title":"EBioMedicine"},{"issue":"9","key":"2891_CR26","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/ndt\/gfaf045","volume":"40","author":"BT van den Berge","year":"2025","unstructured":"van den Berge BT, van den Broek M, Di Giovanni G, Debiec H, Gloudemans S, Leusink Q, den Braanker D, Wetzels JFM, Ronco P, Smeets B, Jansen J, Maas RJ. Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome. Nephrol Dial Transpl. 2025;40(9):1736\u201345.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"2891_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000202005","volume":"27","author":"F Becherucci","year":"2009","unstructured":"Becherucci F, Mazzinghi B, Ronconi E, Peired A, Lazzeri E, Sagrinati C, Romagnani P, Lasagni L. The role of endothelial progenitor cells in acute kidney injury. Blood Purif. 2009;27(3):261\u201370.","journal-title":"Blood Purif"},{"key":"2891_CR28","doi-asserted-by":"crossref","unstructured":"\u010ci\u017eman B, Butler EL, Stavas J, Prakash R, Saad T, Silva A, Wooldridge T, Aqeel A, Yan H, Barysauskas CM, Culleton B. A Randomized clinical trial of kidney autologous cell therapy in diabetic kidney disease. Clin J Am Soc Nephrol. 2026 Jan 2.","DOI":"10.2215\/CJN.0000000969"},{"issue":"1","key":"2891_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/MS9.0000000000004306","volume":"88","author":"M Liu","year":"2025","unstructured":"Liu M, Bian L, Sun H, Zhang P, Liu C, Wang L. Global clinical landscape of stem cells in CKD: clinical trials, challenges, and opportunities. Ann Med Surg (Lond). 2025;88(1):976\u20139.","journal-title":"Ann Med Surg (Lond)"},{"issue":"2","key":"2891_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000527582","volume":"52","author":"J Stavas","year":"2023","unstructured":"Stavas J, Thajudeen B, Coca S, Silva A, Butler E, Detwiler R, Burgner A. Renal autologous cell therapy in Type 2 Diabetes with late stage 4 diabetes-related chronic kidney disease: trial design and early analysis. Blood Purif. 2023;52(2):114\u201321.","journal-title":"Blood Purif"},{"issue":"4","key":"2891_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41431-019-0537-8","volume":"28","author":"S Daga","year":"2020","unstructured":"Daga S, Donati F, Capitani K, Croci S, Tita R, Giliberti A, Valentino F, Benetti E, Fallerini C, Niccheri F, Baldassarri M, Mencarelli MA, Frullanti E, Furini S, Conticello SG, Renieri A, Pinto AM. New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells. Eur J Hum Genet. 2020;28(4):480\u201390.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"2891_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.kint.2018.06.034","volume":"94","author":"N Ashammakhi","year":"2018","unstructured":"Ashammakhi N, Wesseling-Perry K, Hasan A, Elkhammas E, Zhang YS. Kidney-on-a-chip: untapped opportunities. Kidney Int. 2018;94(6):1073\u201386.","journal-title":"Kidney Int"},{"key":"2891_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jconrel.2022.06.049","volume":"349","author":"TT Tang","year":"2022","unstructured":"Tang TT, Wang B, Lv LL, Dong Z, Liu BC. Extracellular vesicles for renal therapeutics: State of the art and future perspective. J Control Release. 2022;349:32\u201350.","journal-title":"J Control Release"},{"issue":"11","key":"2891_CR34","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.3390\/molecules27113442","volume":"27","author":"CY Zhang","year":"2022","unstructured":"Zhang CY, Fu CP, Li XY, Lu XC, Hu LG, Kankala RK, Wang SB, Chen AZ. Three-dimensional bioprinting of decellularized extracellular matrix-based bioinks for tissue engineering. Molecules. 2022;27(11):3442.","journal-title":"Molecules"},{"key":"2891_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.biomaterials.2018.08.006","volume":"198","author":"AK Miri","year":"2019","unstructured":"Miri AK, Khalilpour A, Cecen B, Maharjan S, Shin SR, Khademhosseini A. Multiscale bioprinting of vascularized models. Biomaterials. 2019;198:204\u201316.","journal-title":"Biomaterials"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02891-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02891-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02891-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:58:59Z","timestamp":1784282339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02891-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2891"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02891-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no conflict of interestexists.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There was no requirement for informed consent from patients since it was a manuscript by the physician based on current scientific evidence.","order":3,"name":"Ethics","label":"Informed consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}